Expertise in
1
conditions

Marco Vaira

Candiolo, IT 
Expertise in
1
conditions
Candiolo, IT 

Overview

Marco Vaira practices practicing medicine in Candiolo, Italy.

Mr. Vaira is highly rated in 1 condition, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Appendix Cancer, Colorectal Cancer, and Ovarian Cancer.

He is actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Candiolo, Italy
Other Locations
Turin, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Feasibility, Efficacy and Safety of Pressurized IntraPeritoneal Air-flow Chemotherapy (PIPAC) With Oxaliplatin, Cisplatin and Doxorubicin in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancers and Primary Tumors of the Peritoneum: An Open-label, Two-arms, Phase I-II Clinical Trial. PI-CaP
Feasibility, Efficacy and Safety of Pressurized IntraPeritoneal Air-flow Chemotherapy (PIPAC) With Oxaliplatin, Cisplatin and Doxorubicin in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancers and Primary Tumors of the Peritoneum: An Open-label, Two-arms, Phase I-II Clinical Trial. PI-CaP
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

48 Total Publications

Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centers.
Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centers.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: March 07, 2024

Frequently Asked Questions about Marco Vaira

Is Marco Vaira a top-rated expert for Pseudomyxoma Peritonei?

MediFind is an objective health platform that identifies experts based on real-world data. Marco Vaira is classified as an Advanced expert for Pseudomyxoma Peritonei, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marco Vaira participate in research or clinical trials?

Yes. Marco Vaira has published 48 articles and abstracts on conditions like Pseudomyxoma Peritonei. You can view a list of Marco Vaira's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vaira's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile